Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vanguard Russell 2000 Growth ETF
(NQ:
VTWG
)
239.73
UNCHANGED
Streaming Delayed Price
Updated: 1:15 PM EST, Nov 28, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vanguard Russell 2000 Growth ETF
< Previous
1
2
Next >
PACS Group Stock Soars Premarket On Completion Of Audit Committee Probe, Upbeat Full-Year Guidance
↗
November 20, 2025
Via
Stocktwits
MGTX Stock Soared 13% Today – What’s The Eli Lilly Angle?
↗
November 10, 2025
Via
Stocktwits
Intuitive Machines To Acquire Lanteris Space Systems In $800 Million Deal
↗
November 04, 2025
Via
Stocktwits
TG Therapeutics Stock Soars After Company Ups Guidance For Multiple Sclerosis Drug
↗
November 03, 2025
Via
Stocktwits
This Wealth Firm Just Sold $8 Million in Small-Cap Stocks — Here’s Why
↗
October 30, 2025
This Wealth Firm Just Sold $8 Million in Small-Cap Stocks — Here’s Why
Via
The Motley Fool
Topics
ETFs
Regulatory Compliance
BBIO Stock Soars After Experimental Drug Shows Improvement In Inherited Muscle Disorder In Late-stage Trial
↗
October 27, 2025
BridgeBio now intends to file a new drug application for the therapy's approval in the first half of 2026.
Via
Stocktwits
Candel Therapeutics Enters $130M Term Loan Facility To Advance Lead Product Candidate In Treatment Of Lung Cancer
↗
October 14, 2025
Via
Stocktwits
White House Reportedly Denies Plans To Acquire Stake In Critical Metals
↗
October 06, 2025
Via
Stocktwits
Harrow To Acquire Sedation Solutions Developer Melt Pharmaceuticals – More Details Inside
↗
September 26, 2025
Via
Stocktwits
DNUT Stock Trades Above 200-DMA For The First Time Since November 2024
↗
October 22, 2025
Morgan Stanley kept its ‘Underweight’ rating and $2.5 price target on Krispy Kreme.
Via
Stocktwits
Topics
ETFs
Beyond Meat Stock Skyrockets 60% Today: Meme Stock Frenzy Intensifies After ETF Inclusion Amid Surging Retail Buzz
↗
October 22, 2025
Roundhill Investments said that Beyond Meat has been added to the Roundhill Meme Stock ETF.
Via
Stocktwits
Topics
Artificial Intelligence
ETFs
SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment
↗
October 13, 2025
SELLAS said that in a study model, SLS009 monotherapy and the combination prolonged overall survival compared to Venetoclax alone, with a statistically significant difference.
Via
Stocktwits
Capricor Stock Rises Pre-Market Over Fresh Hopes of Deramiocel Approval In Treating Genetic Disorder
↗
September 25, 2025
Via
Stocktwits
Actuate Therapeutics Stock Rises After Updating FDA Application For Lead Investigational Drug In Treating Pancreatic Cancer
↗
September 22, 2025
Actuate on Monday also said that its recent $17.25 million public offering provides an extended runway into the second half of 2026.
Via
Stocktwits
KalVista Pharmaceuticals’ Hereditary Angioedema Drug Approved In EU, Switzerland: Retail Sees Stock Rallying To $22 In A Year
↗
September 19, 2025
Via
Stocktwits
Why Is aTyr Stock Falling Today?
↗
September 15, 2025
Via
Stocktwits
Immunome Stock Rises After Craig-Hellum Initiates Coverage With $26 Price Target: Here’s Why The Analyst Sees An ‘Attractive Entry Point’
↗
September 05, 2025
Via
Stocktwits
Krispy Kreme Stock Pops After FBI Director Kash Patel Reportedly Endorses It As A ‘Good Investment’: Retail Chatter Soars Over 600%
↗
September 18, 2025
Via
Stocktwits
Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants
↗
September 11, 2025
In consideration for the immediate exercise of the warrants in full, the institutional investor will receive new, unregistered warrants in a private placement to purchase up to 19.69 million shares of...
Via
Stocktwits
Anavex Life Sciences Stock Rises After Experimental Alzheimer’s Drug Slows Cognitive Decline In Study
↗
September 09, 2025
After 48 weeks, patients receiving 30 mg once-daily oral Blarcamesine demonstrated barely detectable cognitive decline, the company said.
Via
Stocktwits
Novavax COVID-19 Vaccine Approved In Japan, Triggers Milestone Payment From Partner Takeda
↗
September 04, 2025
Via
Stocktwits
FDA Says No Advisory Committee Meeting Needed For Aquestive’s Oral Epinephrine Film
↗
September 04, 2025
Via
Stocktwits
Tectonic Stock Soars Pre-market After Tuesday’s Sell-Off: Oppenheimer Is Hopeful About Company’s Lead Candidate
↗
September 03, 2025
Via
Stocktwits
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail
↗
August 14, 2025
Via
Stocktwits
US FDA Withdraws Approval For Amylyx’s Neurodegenerative Disorder Drug, But BofA Hikes Price Target
↗
August 28, 2025
Bank of America analyst Tim Anderson raised the firm's price target on Amylyx to $14 from $10 while keeping a ‘Buy’ rating on the shares after the company reiterated earlier this week that it has a...
Via
Stocktwits
X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target
↗
August 13, 2025
The company said that the originally announced offering of $60 million was increased to $85 million to allow for the inclusion of an investor who had a pre-existing investment right.
Via
Stocktwits
Topics
Economy
CervoMed Dementia Drug Slows Disease Progression In Study: Retail Loads Up On The Stock
↗
July 28, 2025
The company is now poised to initiate late-stage trials for Neflamapimod.
Via
Stocktwits
This Pharma Stock Rose 200% On Monday Morning And Retail Says Valuation Could Rise To $5B: Here’s Why
↗
July 28, 2025
Sara Hurvitz, co-principal investigator for the trial, said that the data for both combination treatments in the trials are “potentially practice-changing.”
Via
Stocktwits
Topics
Death
Capricor Stock Plunges Pre-Market After US FDA Declines Approval For Muscular Disorder Therapy
↗
July 11, 2025
The FDA told Capricor in a letter that it is unable to approve its application for Deramiocel in its current form as it does not meet the requirement for substantial evidence of effectiveness and...
Via
Stocktwits
Vanguard Has 10 Different Small-Cap Exchange-Traded Funds (ETFs). Which Should You Buy Right Now?
↗
February 22, 2025
You might be surprised at how many ways you can passively invest in small-cap stocks.
Via
The Motley Fool
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.